W
WAVEMAN · COMPANY
GH · Guardant Health, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

GH

Guardant Health, Inc.
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001576280
C-SUITE BUYING · 1FORM 144 · 15☆ WATCH
INSIDER NET · 180D
-$119.7M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
362
13F, latest reported quarter
REVENUE GROWTH
+32.9%
XBRL, annual
NET MARGIN
-42.4%
CONVERSIONS · 180D
121
codes C/M, not in net · $8.6M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$119.7M over 180 days
-$68.3M over 90 days
below 89% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
362 funds added or opened last quarter
more than 93% of Healthcare Services
REVENUE
+32.9% year over year
more than 81% of Healthcare Services
MARGIN
-42.4% net margin
below 87% of Healthcare Services
BUYBACKS
$45.0M repurchased, FY to 2025-12-31
below 52% of Healthcare Services
SHORT
8.5% of shares outstanding short · 5.4 days to cover · settled 2026-07-31
more than 83% of Healthcare Services
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$119.7M across 13 people in 180 days.
362 funds added or opened positions in the latest 13F quarter, of 603 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +142.1%
+142.1%12M
-18%+41%+99%+157%2025-092025-102025-122026-032026-052026-072026-09 2025-09-09 · Eltoukhy Helmy sold $17.5M2026-06-29 · Talasaz AmirAli sold $10.7M2026-06-26 · Talasaz AmirAli sold $9.6M2025-12-15 · Eltoukhy Helmy sold $8.7M2026-06-26 · Talasaz AmirAli sold $8.0M2026-06-29 · Talasaz AmirAli sold $7.1M2026-06-05 · Eltoukhy Helmy sold $6.2M2026-08-10 · Freeman Chris sold $6.0M2026-05-12 · Talasaz AmirAli sold $5.0M2026-06-05 · Eltoukhy Helmy sold $4.3M2026-05-20 · Talasaz AmirAli sold $4.2M2026-05-20 · Talasaz AmirAli sold $4.1M2026-06-29 · Talasaz AmirAli sold $3.9M2026-05-20 · Talasaz AmirAli sold $3.6M2026-08-21 · Talasaz AmirAli sold $3.5M2025-12-08 · Talasaz AmirAli sold $3.2M2026-05-20 · Talasaz AmirAli sold $3.2M2026-08-12 · Monroe Terilyn J. sold $3.1M2026-05-20 · Talasaz AmirAli sold $3.0M2026-08-10 · Freeman Chris sold $3.0M2026-05-22 · Freeman Chris sold $2.9M2026-03-04 · Kalia Kumud sold $2.6M2025-12-01 · Monroe Terilyn J. sold $2.5M2025-12-05 · Bell Michael Brian sold $2.3M2026-05-20 · Talasaz AmirAli sold $2.3M2026-08-12 · Monroe Terilyn J. sold $2.2M2025-12-01 · Monroe Terilyn J. sold $2.0M2025-12-05 · CLARK IAN T sold $1.8M2026-06-05 · Eltoukhy Helmy sold $1.8M2026-08-12 · Monroe Terilyn J. sold $1.6M2025-12-08 · Talasaz AmirAli sold $1.6M2026-08-21 · Talasaz AmirAli sold $1.5M2026-08-04 · CLARK IAN T sold $1.4M2025-12-08 · Chudova Darya sold $1.4M2026-08-21 · Talasaz AmirAli sold $1.3M2026-05-20 · Talasaz AmirAli sold $1.3M2026-05-27 · Saia John G. sold $1.3M2026-03-04 · Kalia Kumud sold $1.2M2025-12-05 · Bell Michael Brian sold $1.2M2026-08-10 · Freeman Chris sold $1.2M2026-06-04 · Krognes Steve E. sold $1.2M2025-12-05 · Freeman Chris sold $1.2M2026-08-21 · Talasaz AmirAli filed to sell $6.3M2026-08-17 · Tariq Musa filed to sell $18.1K2026-08-12 · Monroe Terilyn J. filed to sell $7.6M2026-08-10 · Freeman Chris filed to sell $10.8M2026-08-05 · Joyce Meghan V. filed to sell $1.8M2026-08-05 · Hidalgo Medina Manuel filed to sell $279.2K2026-08-04 · CLARK IAN T filed to sell $2.3M2026-07-16 · Tariq Musa filed to sell $18.9K2026-07-01 · Joyce Meghan V. filed to sell $660.0K2026-06-26 · Joyce Meghan V. filed to sell $300.1K2026-06-26 · Talasaz AmirAli filed to sell $39.2M2026-06-24 · Joyce Meghan V. filed to sell $280.0K2026-06-22 · Joyce Meghan V. filed to sell $812.6K2026-06-22 · Tariq Musa filed to sell $255.9K2026-06-22 · POTTER MYRTLE S filed to sell $204.1K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $119.7M sold by insiders over 180 days, 362 funds added last quarter, $70.9M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHADUSSERABDSXENSG
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Guardant Health, Inc. insiders sold a net $119.7M of stock across 230 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Talasaz AmirAli
Co-Chief Executive Officer
SELL
2026-08-21
9,023.0
$1.5M
Talasaz AmirAli
Co-Chief Executive Officer
SELL
2026-08-21
20,888.0
$3.5M
Talasaz AmirAli
Co-Chief Executive Officer
SELL
2026-08-21
7,589.0
$1.3M
Tariq Musa
Director
SELL
2026-08-17
116.0
$18.1K
Monroe Terilyn J.
Chief People Officer
SELL
2026-08-12
3,704.0
$605.3K
230 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 225 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
7,622,935.0 sh
$1.1B
VANGUARD CAPITAL MANAGEMENT LLC
5,755,857.0 sh
$863.6M
FMR LLC
5,488,272.0 sh
$823.4M
VANGUARD PORTFOLIO MANAGEMENT LLC
5,445,785.0 sh
$817.0M
Invesco Ltd.
4,429,755.0 sh
$664.6M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Talasaz AmirAli
FILED 2026-08-21
$6.3M
Tariq Musa
FILED 2026-08-17
$18.1K
Monroe Terilyn J.
FILED 2026-08-12
$7.6M
Freeman Chris
FILED 2026-08-10
$10.8M
Joyce Meghan V.
FILED 2026-08-05
$1.8M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Franklin Genomic Advancements ETF
$1.5M POSITION · AS OF 2026-03-31
6.8%
Eventide Gilead Fund
$148.3M POSITION · AS OF 2026-03-31
5.5%
Global X Genomics & Biotechnology ETF
$2.5M POSITION · AS OF 2026-02-28
4.7%
Eventide Exponential Technologies Fund
$3.3M POSITION · AS OF 2026-03-31
4.4%
F/m Emerald Life Sciences Innovation ETF
$4.1M POSITION · AS OF 2026-02-28
4.3%
Eventide Healthcare & Life Sciences Fund
$64.7M POSITION · AS OF 2026-03-31
4.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 6 registered trials, 6 still enrolling or running — a status change here is dated weeks before the press release
6
Not applicable
6 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$982.0M$739.0M$563.9M$449.5M
OPERATING INCOME$-437.2M$-443.6M$-564.7M$-544.4M
NET INCOME$-416.3M$-436.4M$-479.4M$-654.6M
EPS (DILUTED)-3.32-3.56-4.28-6.41
OPERATING CASH FLOW$-184.8M$-239.9M$-325.0M$-309.5M
CASH$378.2M$525.5M$1.1B$141.6M
LONG-TERM DEBT$1.5B$1.1B——
BUYBACKS$45.0M$0$0—
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →